Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business Update

TORRANCE, Calif., Nov. 14, 2022 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its results of operations and financial condition as of and for the three and nine…